1. Volume 150, Issue 2, Pages 312-314 (February 2016)
Novel Transarterial Biomimetic-Based Nanoparticles for the Treatment of Hepatocellular Carcinoma 
Riccardo Lencioni 
Gastroenterology 
Volume 150, Issue 2, Pages (February 2016)
DOI: /j.gastro
Copyright © 2016 AGA Institute Terms and Conditions

2. Figure 1
Intraoperative fluorescent-navigated tissue resection in hepatocellular carcinoma (HCC). Illustration showing the potential low-density lipoprotein (LDL)–docosahexaenoic acid (DHA) nanoparticles in intraoperative fluorescent navigation imaging to treat HCC patients. Based in part on the data presented by Wen et al.6 Additionally, nanoparticles coupled with antibody complexes that specifically recognize malignant liver cells11 could result in a much higher efficacy in the removal of HCC affected tissue. FITC, fluorescein isothiocyanate.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions